Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case reportChristian Koch, Juliane Fleischer, Todor Popov, Karl Frontzek, Bettina Schreiner, Patrick Roth, Markus G. Manz, Simone Unseld, Antonia M. S. Müller, Norman F. Russkamp
23 January 2023
Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancerJulia Karbach, Dragan Kiselicki, Kathrin Brand, Claudia Wahle, Evgueni Sinelnikov, Dirk Gustavus, Hans Hoffmeister, Hans-Bernd Prisack, Akin Atmaca, Elke Jäger
10 January 2023
Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumabRaanan Berger, Gal Dinstag, Omer Tirosh, Eyal Schiff, David Kleiner, Kenneth D Aldape, Eytan Ruppin, Tuvik Beker, Razelle Kurzrock
9 December 2022
Dasatinib for treatment of CAR T-cell therapy-related complicationsKatharina Baur, Dominik Heim, Astrid Beerlage, Anna S Poerings, Bastian Kopp, Michael Medinger, Jan C Dirks, Jakob R Passweg, Andreas Holbro
1 December 2022
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravisWen Gao, Lingxiang Wu, Shidai Jin, Jun Li, Xinyin Liu, Jiali Xu, Wei Zhang, Qixing Gong, Chunxiao Sun, Wei Wang, Zidun Wang, Yang W Shao, Jiani C Yin, Lu Shen, Liang ChenSee the full list of authors
30 November 2022
Tumoral melanosis mimicking residual melanoma in the setting of talimogene laherparepvec treatmentSong Y Park, Austin R Green, Rouba Hadi, Coley Doolittle-Amieva, Jennifer Gardner, Ata S Moshiri
28 October 2022
First communication on the efficacy of combined Lutetium-PSMA with immunotherapy outside prostate cancerAntonia Digklia, Sarah Boughdad, Krisztian Homicsko, Clarisse Dromain, Mounir Trimech, Ana Dolcan, Solange Peters, John Prior, Niklaus Schaefer
26 October 2022
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cellsNiklas Kehl, Michael Kilian, Julius Michel, Tim R Wagner, Sebastian Uhrig, Alexander Brobeil, Lilli-Sophie Sester, Sven Blobner, Simon Steiger, Michael Hundemer, Niels Weinhold, Karsten Rippe, Stefan Fröhling, Stefan B Eichmüller, Lukas BunseSee the full list of authors
17 October 2022
Durable response of anaplastic thyroid carcinoma to FS118, a bispecific LAG-3/PD-L1 antibody, after checkpoint inhibitor progression: a case reportMaxwell J Kroloff, Josefin-Beate Holz, Omer Stern, Christopher J Shepherd, Michelle Morrow, Louis Kayitalire, Deborah J Wong
6 October 2022
Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case reportDan Li, Yimei Que, Shengnan Ding, Guang Hu, Wen Wang, Xia Mao, Ying Wang, Chunrui Li, Liang Huang, Jianfeng Zhou, Wei Zhang, Min Xiao
22 September 2022